Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ENBREL
- Immune Effects of Vedolizumab With or Without Anti-TNF Pre-treatment in T1D
- Etanercept Therapy for Nails Psoriasis Monitoring With Noninvasive Imaging
- Study to Assess the Safety and Efficacy of Enbrel Administered by Sofusa DoseConnect for Rheumatoid Arthritis
- Understanding GWI: Integrative Modeling
- TNF and Glucocorticoid Antagonist for GWI Associated Multi-symptom Disease Homeostasis Reset
- Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel
- Advanced Therapeutics in Rheumatoid Arthritis (RA)
- Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis
- Etanercept Plus Methotrexate Versus Methotrexate Alone in Children With Polyarticular Course Juvenile Rheumatoid Arthritis
- Safety and Efficacy of Etanercept (Recombinant Human Tumor Necrosis Factor Receptor Fusion Protein [TNFR:Fc]) in Children With Juvenile Rheumatoid Arthritis (JRA)
- Pilot Study Evaluating The Efficacy Of Etanercept In Acute Gout
- A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants
- Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
- Efficacy, Safety and Immunogenicity of Enerceptan Compared to Enbrel in Rheumatoid Arthritis
- Pharmacokinetic, Safety and Tolerability Study of Altebrel in Healthy Male Subjects
- Stem Cell Mobilization (Plerixafor) and Immunologic Reset in Type 1 Diabetes (T1DM)
- Niclosamide With Etanercept in Rheumatoid Arthritis
- Prediction of the Answer to the Treatment by Biotherapies for Naive Spondyloarthritis by Combinatorial Analysis of Serum Biomarkers
- NATIENS: Optimal Management and Mechanisms of SJS/TEN
- Study to Assess the Injection Site Pain Associated With a New Etanercept Formulation in Adults With Rheumatoid Arthritis or Psoriatic Arthritis
- Relapse of Ankylosing Spondylitis Patients Withdrawal Etanercept After Clinical Remission: a Following-up Study
- Study to Evaluate the Efficacy of Etanercept Treatment in Adults Who Failed Therapy With Apremilast
- Anti-inflammatory Therapy to Improve Outcomes After TPIAT
- Targeted Therapy Using Intradermal Injection of Etanercept for Remission Induction in Discoid Lupus Erythematosus
- Dose Reduction of Etanercept in Patients With Ankylosing Spondylitis
- Comparative Efficacy and Safety Study of GP2015 and Enbrel® in Patients With Rheumatoid Arthritis
- A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis.
- Tolerance, Pharmacokinetics and Preliminary Efficacy of T0001 in RA (Rheumatoid Arthritis)
- Etanercept and Methotrexate in Combination or as Monotherapy in Psoriatic Arthritis
- Treatments Against RA and Effect on FDG-PET/CT
- Study of Etanercept Monotherapy vs Methotrexate Monotherapy for Maintenance of Rheumatoid Arthritis Remission
- A Study Comparing LBEC0101 to Enbrel® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy
- Mechanistic Studies of B- and T-Cell Function in RA Patients Treated With TNF Antagonists, Tocilizumab, or Abatacept
- An Observational Monocentric Study Investigating the Association Between Trough Serum Levels of Etanercept, Antibodies Towards Etanercept and Its Effectiveness in Psoriasis Patients
- Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Patients With Plaque Psoriasis
- Anti-TNFα Use During Elective Foot and Ankle Surgery in Patients With Rheumatoid Arthritis
- Defining Remission With Etanercept in AS in Real Life Clinical Practice
- Study With Etanercept Focusing on Remission and Predictability of Remission in Real Life Clinical Practice
- Effects of Treatment With Biological Agents on Vascular and Cardiac Function in Psoriasis
- Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)
- ASIS for GAMMAGARD in Primary Immunodeficiency
- Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
- ASIS for Enbrel in Plaque Psoriasis
- Etanercept in Rheumatoid Arthritis and Vascular Inflammation
- Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
- TNF-alpha Inhibition in CRPS: A Randomized Controlled Trial
- Etanercept and Vascular Function in Psoriasis
- The Immunological Basis for Treatment Resistance to Anti-TNF Treatments
- Etanercept and Celecoxib Alone/Combined Treatment in Effectiveness and Safety of Active Ankylosing Spondylitis
- Entecavir for Biological Agents Associated HBV Reactivation in Inflammatory Arthritis Patients
- Study to Evaluate the Ability of Subjects With Rheumatoid Arthritis or Psoriatic Arthritis to Effectively Use a Reusable Autoinjector to Self-inject Etanercept
- A Study Comparing SB4 to Enbrel® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy
- Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Etanercept (GP2015) and Enbrel
- Stopping TNF Alpha Inhibitors in Rheumatoid Arthritis
- An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate
- Limitation of Ischemic Injury of a Kidney Stored in Machine Perfusion in Hypothermia - Evaluation of the Impact on Kidney Allograft Function
- Study to Compare the Safety and Pharmacokinetic Characteristics of LBEC0101 25mg With Those of Enbrel®
- Swiss Dermatology Network of Targeted Therapies (SDNTT)
- Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis
- Comparison the Safety and Pharmacokinetic Characteristics of DWP422 25 mg With Those of ENBREL 25MG PFS INJ. After Subcutaneous Injection in Healthy Male Volunteers
- Prospective Evaluation of the Radiographic Efficacy of Enbrel
- Ultrasound and Withdrawal of Biological DMARDs in Rheumatoid Arthritis
- Characterize Patients With Moderately Active Rheumatoid Arthritis (RA)
- RHYTHM (Formerly Escape II Myocardium)
- Post Marketing Surveillance To Observe Safety And Efficacy Of Enbrel In Pediatric Patients With Psoriasis
- Work Productivity in Active Ankylosing Spondylitis (AS) Patients Treated With Enbrel.
- A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient Department
- Comparison of Two Etanercept Regimens (REUMATOCEPT® Versus ENBREL®) for Treatment of Rheumatoid Arthritis
- Etanercept Treating Patient With Acute ST Segment Elevated Myocardial Infarction
- Efficacy and Safety of Etanercept 50 mg Once Weekly Plus As Needed Topical Agent in Moderate to Severe Plaque Psoriasis
- Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
- Etanercept and Methotrexate in Patients to Induce Remission in Early Arthritis (EMPIRE)
- A Study to Evaluate the NSAIDS Sparing Effect of Etanercept in Subjects With Axial Spondyloarthritis
- Etanercept (Enbrel) in Ankylosing Spondylitis
- Etanercept (Enbrel) in Undifferentiated Spondyloarthritis
- Withdrawal of Etanercept After Successful Treatment of Juvenile Idiopathic Arthritis
- A Study to Assess the Effect of Ustekinumab (Stelara®) and Etanercept (Enbrel®) in Participants With Moderate to Severe Psoriasis (MK-0000-206)
- Study Comparing Etanercept (ETN) Against a Placebo for Etanercept on a Background Nonsteroidal Anti Inflammatory Drug (NSAIDs) in the Treatment of Early Spondyloarthritis (SpA) Patients Who do Not Have X-ray Structural Changes
- Etanercept (Enbrel) Special Investigation (Regulatory Post Marketing Commitment Plan)
- Observational Non-Interventional Study With Enbrel (Etanercept) in Patients With Ankylosing Spondylitis
- Psoriasis Inflammation and Systemic Co Morbidities
- Study to Compare the Safety and Pharmacokinetic Characteristics of LBEC0101 25 mg With Those of Enbrel®
- Enbrel-Juvenile Idiopathic Arthritis (JIA) Use Results Survey [All-Case Surveillance]
- Study Evaluating the Safety and Effectiveness of Etanercept for the Treatment of Pediatric Psoriasis
- A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
- T Cells and TNF (Tumor Necrosis Factor): The Impact of TNF Blockade
- Can We Miss Pigmented Lesions in Psoriasis Patients?
- Etanercept for the Treatment of Chronic Urticaria
- Optimal Management of Rheumatoid Arthritis Patients Requiring Biologic Therapy
- Human Tumor Necrosis Factor Alpha (TNFa)-Induced Pre-B Cell Bone Marrow Emigrants
- Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA)
- The Efficacy and Safety of Adding Methotrexate to Etanercept in Psoriasis
- A Study to Investigate the Ability of GSK706769 to Maintain Clinical Remission After Withdrawal of Enbrel in Rheumatoid Arthritis Patients
- Safety and Efficacy of Etanercept in Patients With Psoriasis Who Failed to Respond to Other Biologic Treatments
- Pilot Study of Etanercept (Enbrel) in Children With Fanconi Anemia
- Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis
- Alefacept in Subjects With Chronic Plaque Psoriasis Who Failed to Respond to Anti-TNF Therapy
- Etanercept: Single Blind Control Study in Ocular Manifestations of Behcet's Disease
- Study Evaluating Etanercept Plus Methotrexate in Early Rheumatoid Arthritis
- Effects of Etanercept on the Heart, Veins and Thickness of Certain Major Arteries In Ankylosing Spondylitis Patients
- Open-Label Study Comparing Etanercept to Conventional Disease Modifying Antirheumatic Drug (DMARD) Therapy
- Enbrel-Sulfasalazin-Early-Axial Spondyloarthritis (AS)
- Etanercept in Kawasaki Disease
- Double-blind, Randomized, Placebo-controlled Trial of Etanercept for 12 Months in Subjects With Inclusion Body Myositis
- Open Label Study Etanercept's Maintenance Dose in Obese Patients With Moderate to Severe Plaque Type Psoriasis
- The Safety and Efficacy of Etanercept (Enbrel®) for the Treatment of Discoid Lupus Erythematosus
- Switching Anti-TNF-Alpha Agents in Rheumatoid Arthritis (RA)
- TNF-alpha Antagonists for AECOPD: A Randomized, Double-Blind, Placebo-Controlled Pilot Trial
- Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation
- Islet After Kidney Transplant for Type 1 Diabetes
- Efficacy and Safety of TAK-783 in Subjects With Rheumatoid Arthritis
- Safety and Efficacy of TAK-715 in Subjects With Rheumatoid Arthritis
- Etanercept in New Onset Type 1 Diabetes
- The Use of Etanercept Enbrel as Sole Treatment for Grade I Acute Graft Versus Host Disease
- A Proof of Concept and Dose Ranging Study in Patients With Rheumatoid Arthritis
- Observational Study Evaluating Etanercept (Enbrel®) In Subjects With Plaque-Type Psoriasis In Usual Care Settings
- Study Evaluating Efficacy / Safety of Etanercept + Methotrexate Compared to Usual Treatment in Moderate RA Subjects
- Study Evaluating Enbrel Drug Levels in Healthy Male Chinese Subjects
- Use of Etanercept in the Treatment of Moderate to Severe Lichen Planus
- A Study for Patients With Rheumatoid Arthritis on Methotrexate (MTX) With an Inadequate Response to TNFα Inhibitor Therapy
- Study Evaluating the Safety of Enbrel (Etanercept)
- Safety and Efficacy of Combining nbUVB to Etanercept in Patients
- Addition of Etanercept and Extracorporeal Photopheresis (ECP) to Standard Graft-Versus-Host Disease (GVHD) Prophylaxis in Stem Cell Transplant
- Evaluation of Etanercept in Patients With Plaque Psoriasis After Stopping Ciclosporin Therapy
- Study Comparing Etanercept in Combination With Methotrexate in Subjects With Rheumatoid Arthritis
- Study Evaluating The Use Of Etanercept In Patients With Ankylosing Spondylitis
- Etanercept (Enbrel) for Juvenile Myelomonocytic Leukemia
- Study Evaluating the Efficacy of Enbrel (Etanercept) in Subjects in Japan
- Study Evaluating the Safety and Efficacy of Enbrel (Etanercept) in Japan
- Observational Trial With Enbrel
- Study Evaluating the Tolerance and Safety of Enbrel (Etanercept) in Adults and Children
- Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis
- Etanercept for the Treatment of Lupus Nephritis
- Trial of Early Aggressive Drug Therapy in Juvenile Idiopathic Arthritis
- Tumor Necrosis Factors (TNF)-α Blockade for Psoriatic Arthritis
- Tumor Necrosis Factor Decreases Vitamin D Dependant Calcium Absorption
- Effectiveness of Etanercept for Idiopathic Pneumonia Syndrome Following Stem Cell Transplantation (BMT CTN 0403)
- Study Evaluating Etanercept for the Treatment of Active, Severe, and Advanced Axial Ankylosing Spondylitis
- Study of TNF-Antagonism in the Metabolic Syndrome (II)
- Extension Study Evaluating Etanercept in Ankylosing Spondylitis
- Study of TNF-Antagonism in Metabolic Syndrome
- Rheumatoid Arthritis: Comparison of Active Therapies in Patients With Active Disease Despite Methotrexate Therapy
- A Placebo-Controlled Double-Blind Study on the Safety and Efficacy of Etanercept in Palmoplantar Pustulosis
- Observational Safety Study of Etanercept (Enbrel) for Treatment of Psoriasis
- Open-label, Pilot Protocol of Patients With Rheumatoid Arthritis Who Switch to Infliximab After Incomplete Response to Etanercept
- Double-blind, Randomized, Placebo-controlled Phase 3 Study of Etanercept in the Treatment of Psoriatic Arthritis and Psoriasis
- Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant
- Safety and Tolerability of Rituxan With Methotrexate and Etanercept or Methotrexate and Adalimumab in Patients With Active Rheumatoid Arthritis
- Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Dermatologists
- Safety and Efficacy Study of the Effect of Etanercept in Hemodialysis Patients
- Use of Etanercept in the Treatment of Moderate to Severe Lichen Planus
- Enbrel Liquid Immunogenicity Protocol
- Study Evaluating Enbrel in Patients With Rheumatoid Arthritis
- Study Comparing Enbrel (Etanercept) Plus Methotrexate Versus Enbrel Alone in Active Rheumatoid Arthritis Despite Current Methotrexate Therapy
- Phase II Trial of Enbrel in Patients With Primary Systemic Amyloidosis
- Etanercept and Gemcitabine in Patients With Advanced, Chemotherapy Naive Pancreatic Adenocarcinoma
- Etanercept and Rituximab in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
- Study Investigating Enbrel Treatment for Ankylosing Spondylitis
- A Drug Use Investigation of ENBREL for Post-marketing Surveillance (PMS) for RA and PsA
- Study Evaluating Enbrel In Adults With Active Rheumatoid Arthritis In Luxemburg
- Study of Etanercept for the Prevention of Complications Resulting From Hematopoietic Stem Cell Transplantation (HSCT)
- Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell Transplant
- The Use of Etanercept (Enbrel®) in the Treatment of Acute Graft-Versus-Host Disease
- Study of Etanercept (Enbrel) in the Treatment of Pemphigus Vulgaris
- Study of the Efficacy and Safety of Etanercept in Adults With Vitiligo
- Study of Enbrel in Rheumatoid Arthritis (RA) Subjects With Comorbid Disorders
- REPArE: Rating Evaluations in Psoriatic Arthritis (PsA) With Etanercept (Enbrel®)
- Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia
- REKinDLE: Registry With Enbrel® or Kineret® in a Database Using Longitudinal Evaluations
- Azacitidine and Etanercept in Treating Patients With Myelodysplastic Syndromes
- Rheumatoid Arthritis DMARD Intervention and UtilizationStudy
- Organization of Teratology Information Services (OTIS) Autoimmune Diseases in Pregnancy Project
- Study to Help Understand the Action of the Drug Etanercept for the Adult Patient With Psoriasis
- Enbrel® in Psoriatic Arthritis
- Utilization of Narrow Band Ultraviolet B (UVB) Light Therapy and Etanercept for the Treatment of Psoriasis
- Etanercept for Treatment of Hidradenitis
- Effectiveness and Safety of Enbrel® (Etanercept) in Rheumatoid Arthritis Subjects Who Have Failed Remicade® (Infliximab)
- Preference of Rheumatoid Arthritis (RA) Patients of Enbrel® (Etanercept) Auto-Injector Versus Enbrel® Pre-Filled Syringes
- Safety and Efficacy Study of Etanercept (Enbrel) on the Response Rate of HIV-infected Subjects
- Etanercept (Enbrel®) in Psoriasis - Pediatrics
- Safety and Efficacy Study of Etanercept (Enbrel®) In Children With Systemic Onset Juvenile Rheumatoid Arthritis
- Registry of Etanercept (Enbrel®) In Children With Juvenile Rheumatoid Arthritis
- Treatment of Resistant Langerhans Cell Histiocytosis With ENBREL
- Evaluation of Efficacy and Mechanisms of an Antiinflammatory Intervention for Chemotherapy Related Mucosal Injury
- Etanercept for Non-Infectious Lung Injury Following Bone Marrow Transplantation
- The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on Uveitis Associated With Juvenile Rheumatoid Arthritis
- Etanercept (Enbrel) to Treat Pain and Swelling After Third Molar Extraction
- Etanercept for Wegener's Granulomatosis
- Study of Etanercept and Celecoxib to Treat Temporomandibular Disorders (Painful Joint Conditions)
- Etanercept Therapy for Sjogren's Syndrome
- Etanercept to Treat Wegener's Granulomatosis
- Study of TNFR:Fc (Enbrel) in the Treatment of Asthma
- TNRF:Fc to Treat Eye Inflammation in Juvenile Rheumatoid Arthritis
- Blocking Tumor Necrosis Factor in Ankylosing Spondylitis
Clinical trials list
click for details